Role of the GLUT 2 Glucose Transporter in the Response of the L-type Pyruvate Kinase Gene to Glucose in Liver-derived Cells*

(Received for publication, July 8, 1996, and in revised form, April 1, 1997)

Bénédicte Antoine Dagger §, Anne-Marie Lefrançois-Martinez Dagger , Gilles Le Guillou Dagger , Armelle Leturque §par , Alain Vandewalle ** and Axel Kahn Dagger

From the Dagger  Institut National de la Santé et de la Recherche Médicale U.129, Institut Cochin de Génétique Moléculaire, Université René Descartes, 75014 Paris, France, the par  Centre de Recherche sur l'Endocrinologie Moléculaire et le Développement, CNRS, 9 rue Jules Hetzel, 92190 Meudon, France, and the ** Institut National de la Santé et de la Recherche Médicale U.246, Institut Fédératif de Recherche, Faculté de Médecine Xavier Bichat, B.P.416, 75018 Paris, France

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Twenty-six different hepatoma cell lines established from cancer-prone transgenic mice exhibited a close correlation between expression of the GLUT 2 glucose transporter and activation of the L-type pyruvate kinase (L-PK) gene by glucose, as judged by Northern blot analyses and transient transfection assays. The L-PK gene and a transfected L-PK construct were silent in GLUT 2(+) cells and active in GLUT 2(-) cells cultured in glucose-free medium. Transfection of GLUT 2(-) cells with a GLUT 2 expression vector restored the inducibility of the L-PK promoter by glucose, mainly by suppressing the glucose-independent activity of this promoter. Culture of GLUT 2(-) cells, in which the L-PK gene is constitutively expressed, in a culture medium using fructose as fuel selected GLUT 2(+) clones in which the L-PK gene responded to glucose.

The expression of the L-PK gene in GLUT 2(-) cells cultured in the absence of glucose was correlated with a high intracellular glucose 6-phosphate (Glu-6-P) concentration while under similar culture conditions Glu-6-P concentration was very low in GLUT 2(+) cells. Consequently, a role of GLUT 2 in the glucose responsiveness of glucose-sensitive genes in cultured hepatoma cells could be to allow for Glu-6-P depletion under gluconeogenic culture conditions. In the absence of GLUT 2, glucose endogeneously produced might be unable to be exported from the cells and would be phosphorylated again to Glu-6-P by constitutively expressed hexokinase isoforms, continuously generating the glycolytic intermediates active on the L-PK gene transcription.


INTRODUCTION

Glucose is an important regulator of gene transcription in most prokaryotic and eukaryotic species. In vertebrates, it modulates the expression of genes for enzymes involved in metabolic regulation in the liver and adipose tissue and of insulin in beta  cells of the endocrine pancreas (1). In these three glucose-sensitive tissues, glucose transport and phosphorylation are performed by various isoforms of glucose transporters and hexokinases, respectively. Glucose phosphorylation to glucose 6-phosphate, required for glucose action on the transcriptional machinery (2-6), is mainly mediated by hexokinase (HK)1 II in adipocytes and by hexokinase IV (or glucokinase) in the liver and beta  cells; expression of the glucokinase gene is constitutive in the pancreas and insulin-dependent in the liver due to the existence of two different tissue-specific alternative promoters (7). However, glucokinase is replaced by other insulin-independent hexokinase isoforms (mainly HK I) in cultured hepatoma cell lines (2, 8, 9). Tissues whose function is regulated by glucose also possess particular glucose transporters, GLUT 4 in adipocytes and GLUT 2 in tissues secreting glucose into the blood (liver, small intestine, and proximal tubular cells of the kidney) as well as GLUT 2 in the beta  cells of the islets of Langerhans (10, 11). In pancreas beta  cells, it has been suggested that GLUT 2 and glucokinase are essential components of the "glucose sensor" (12, 13). However, the mechanisms of the GLUT 2-specific role in the regulation of insulin secretion by glucose remain unclear (13, 14).

In most hepatoma cell lines in culture, glucose responsiveness of glucose-dependent genes is lost (15) even when these cells remain well differentiated (2). In fact, expression of glucose-responsive genes is generally constitutive in these cells in which glucokinase is replaced by HK I and GLUT 2 is replaced by GLUT 1, another glucose transporter isoform expressed in most cells not specialized in metabolism regulation, e.g. in cancerous cells (8, 16).

However, we recently succeeded in isolating various well differentiated cell lines that have conserved sensitivity of their transcriptional machinery to glucose (2). Here, we show that glucose responsiveness of the L-PK gene in these cells requires synthesis of GLUT 2, and we suggest that GLUT 2, but not GLUT 1, allows for efflux of glucose endogenously produced by the gluconeogenic pathway when cells are cultured without glucose. Therefore, in the absence of GLUT 2, glucose-responsive genes would be permanently stimulated by glycolytic intermediates of endogeneously produced glucose.


MATERIALS AND METHODS

Cell Lines and Culture

mhAT and mhPKT hepatoma cell lines were derived from transgenic mice synthesizing the SV40 large T and small t antigens in the liver under the direction of either the antithrombin III gene or L-PK gene regulatory sequences (17, 18). Hepatocytes were obtained from transgenic animals of different ages with either normal, fetal (mhPKTf3), or tumoral (mhPKT, mhAT1, and mhAT3) livers and established in culture as described previously (19-21). About 30 mhAT1- and mhAT3-derived subclones were isolated using different selective media, particularly containing fructose as the only carbohydrate source (19, 20). Lines mhPKTf3F1 and F2 were subcloned from mhPKTf3 cells by using such a fructose medium. All hepatoma cell lines were usually grown in Ham's F12/Dulbecco's modified Eagle's medium (v/v), Glutamax medium (Life Technologies, Inc., Chagrin Falls, OH) supplemented with penicillin, streptomycin, 0.1 µM insulin, 1 µM dexamethasone, 1 µM triiodothyronine, and 5% (v/v) fetal calf serum.

Glucose Induction Studies

For the glucose induction studies, cells were cultured in a serum-free medium supplemented with 10 µg/ml transferrin and 100 µg/ml albumin. In general, cells were cultured for 24 h before induction in a glucose-free, serum-free medium supplemented with 1 µM triiodothyronine, 1 µM dexamethasone, and 10 mM lactate ("lactate" conditions). Induction was then performed by replacing lactate with 17 mM glucose for 24 h (or less when mentioned). Induction of the L-PK and GLUT 2 mRNA levels was also analyzed in the presence of various concentrations of glucose for 24 h or in the presence of 17 mM glucose and protein inhibitors, such as 10 mM cycloheximide or 25 mM anisomycin, for the times given in the legend to Fig. 5.


Fig. 5. Parallelism between glucose responsiveness of GLUT 2 and L-PK mRNAs in mhAT3F cells. Time-course and glucose dose-response of L-PK and GLUT 2 endogenous gene expression in mhAT3F cells. A, analysis by Northern blot. After decreasing the levels of L-PK and GLUT 2 mRNAs by culture in 10 mM lactate for 40 h (time 0), cells were cultured with 17 mM glucose, or 17 mM glucose and protein synthesis inhibitors (25 mM anisomycin or 10 mM cycloheximide), or 17 mM glucose and 10 nM insulin for the indicated times. The same blot was sequentially hybridized with the different probes. B, time course of L-PK and GLUT 2 mRNA induction by 17 mM glucose and a quantitative representation of the Northern blot as shown in panel A. C, glucose dose-response of L-PK and GLUT 2 mRNA synthesis. After decreasing their levels by culture for 24 h in 10 mM lactate, cells were grown for 24 h in a medium containing from 2.5 to 17 mM glucose. The mRNAs were analyzed by Northern blot and quantitated versus PABP gene expression by PhosphorImaging. Results are the mean of at least three separate experiments.
[View Larger Version of this Image (35K GIF file)]

Northern Blot Analysis

Total RNAs were isolated from cell lines by lysis in 7 M guanidinium HCl followed by phenol extraction (22). RNAs were denatured with methylmercury (II) hydroxide, were electrophoretically separated on formaldehyde, 1.2% agarose gels, and then were transferred and UV cross-linked to nylon membranes (Hybond N, Amersham Corp.). Prehybridization (1 h with 100 µg/ml salmon sperm DNA) and hybridization were carried out as described previously (19) except that the temperature was 58 °C when rat or human probes were used. Quantitation of the radioactive bands on the nylon membranes was performed using a PhosphorImager (Molecular Dynamics).

The probes for rat L-PK and human poly(A)-binding protein (PABP) sequences have been described previously (19). The specific 341-base pair probe for mouse L-PK cDNA was obtained by reverse transcriptase-polymerase chain reaction of mouse mRNA in the laboratory.2 The probes for rat GLUT 2 (10) and human GLUT 1 (23) sequences were obtained from corresponding expression vectors kindly given by Bernard Thorens (Lausanne, Switzerland). The probe for rat hexokinase I sequence was from the laboratory of D. Granner (24).

Transfection Experiments

The L4L3-119 L-PK/CAT and -119 L-PK/CAT constructs have been described previously (25). Transfection was performed by lipofection using N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methyl sulfate (DOTAP, Boehringer-Mannheim, Mannheim, Germany) according to the manufacturer instructions in cells cultured in glucose-free, serum-free medium for 3-4 h. Five µg of CAT constructs and 2 µg of pRSV-luciferase (or 1 µg of pCMV-GLUT) were cotransfected in 60-mm plastic dishes (Falcon, Oxnard, CA) when cells were 60-80% confluent. After 16 h, the medium containing the liposome-DNA complex was removed and replaced with a 17 mM glucose or a 10 mM lactate medium for 24 h. CAT and luciferase activity assays were performed as described (25). CAT activity was calculated as the percentage of diacetylated form versus nonmetabolized chloramphenicol. Results were expressed as a ratio of CAT activity to luciferase activity to correct for the variable transfectability.

When transfections were performed with pCMV expression vectors, pRSV-luciferase was omitted because of the risk of titration of ubiquitous transcription factors. In such a case, CAT activities were measured in the entire extract of each dish to compensate for the differential growth of the cells (i.e. dilution of the CAT activity) when cultured in glucose versus lactate medium for induction studies. The GlRE-mediated glucose responsiveness of the L-PK promoter was assessed by standardizing the activities obtained with the L4L3-119L-PK/CAT construct according to those obtained with the control -119L-PK/CAT construct.

Immunofluorescence Studies

mhPKTf3 cells were attached to coverslips and treated as described previously by Hughes et al. (26) excepted that permeabilization was done with 0.2% Triton X-100 for 5'. Immunofluorescent staining of GLUT 1 and GLUT 2 was carried out using a 1:100 dilution of antisera kindly provided by B. Thorens (Lausanne, Switzerland) that recognized GLUT1 from human, rat, and mouse and GLUT 2 from rat. Staining of recombinant or endogenous GLUT 2 was also confirmed with other antisera kindly provided by S. W. Cushman (Bethesda, MD) and Luc Pénicaud (Toulouse, France) (data not shown).

Determination of Glucose 6-Phosphate Concentration

Glucose 6-phosphate in cultured hepatoma cells was assayed enzymatically according to Slein (27) as described previously (9).

Statistics

Results are given as means + S.D. Statistical significance of the differences between treatment groups was determined by Student's t test.


RESULTS

Correlation between GLUT 2 mRNA Level and Glucose Responsiveness of the L-PK Gene in 26 Different Hepatoma Cell Lines

Different lines of hepatoma cells were derived from transgenic mice synthesizing the SV40 large T and small t antigens in the liver under the direction of either antithrombin III gene or L-PK gene regulatory sequences (17, 18). Hepatocytes were obtained from fetal or adult transgenic animals with either normal (mhPKTf3) or tumoral livers (mhPKT, mhAT1, and mhAT3 cell lines) and established in culture as described previously (19, 20). Each line was derived from a single clone. Fig. 1A shows that induction of L-PK mRNA accumulation by 17 mM glucose in 26 independent clones was proportional (r = 0.92 by linear regression analysis) to their GLUT 2 mRNA content at the same time. In addition, all these clones also contain more or less GLUT 1 mRNA roughly in reverse proportion to GLUT 2 mRNA (not shown). The results obtained for three clones, which synthesized different amounts of GLUT 2 mRNA when cultured in the presence of 17 mM glucose, are presented in Fig. 1B. In cells with low GLUT 2 mRNA levels, L-PK mRNA accumulation was practically constitutive, independent of glucose concentration in the medium. In contrast, in GLUT 2-expressing cells, the amplitude of the glucose responsiveness of the L-PK mRNA expression was correlated with the GLUT 2 mRNA level. It should be observed that GLUT 2 mRNA accumulation is itself dependent on glucose, as previously demonstrated in hepatocytes and mhAT3F cells (3, 28, 29), whereas abundance of GLUT 1 mRNA was independent of glucose (Fig. 5).


Fig. 1. Strict correlation between GLUT 2 and L-PK mRNA accumulation after glucose induction in a panel of hepatoma cell lines. 26 hepatoma cell lines were cultured for 24 h in a glucose-free medium (lactate conditions) before induction by 17 mM glucose for 24 h. A, plot of GLUT 2 and L-PK mRNA levels for each cell line quantitated by PhosphorImager analysis from the same Northern blot. B, representative Northern blot of L-PK and GLUT 2 mRNA levels in three kinds of clones (i.e. exhibiting low to high glucose responsiveness of the L-PK gene). The amount of loaded RNA (24 µg of total RNAs) was standardized by hybridization with a probe recognizing the unvariant poly(A) binding protein (PABP) mRNA.
[View Larger Version of this Image (23K GIF file)]

To confirm whether the positive correlation between GLUT 2 expression and response of the L-PK gene to glucose was mediated by the L-PK glucose response element (GlRE), we chose 8 clones among the 26 presented in Fig. 1 in which we tested glucose responsiveness of the L4L3-119L-PK/CAT construct (25). It was previously demonstrated that the responsiveness of this construct to glucose was due to the GlRE located from -168 to -144 base pairs with respect to the cap site (25). Fig. 2A shows that induction of the CAT activity in transiently transfected cells was also dependent on GLUT 2 mRNA level. Activity of the transfected L-PK promoter was almost constitutive in GLUT 2(-) cells (mhAT1G8) and inducible in GLUT 2(+) cells (mhAT3F) (Fig. 2B). It is noteworthy that 2 mM fructose was also able to activate the L-PK promoter in GLUT 2(+) cells, in agreement with the known efficiency of GLUT 2 on fructose transport (30).


Fig. 2. Correlation between transcriptional response of the L-PK gene to glucose and GLUT 2 mRNA abundance in hepatoma cell lines. Cell lines were cultured for 24 h in a glucose-free medium before induction by 17 mM glucose. A, plot of the stimulation by glucose of the L4L3-119L-PK/CAT construct versus the simultaneous GLUT 2 mRNA accumulation in eight hepatoma cell lines. GLUT 2 mRNA levels were quantitated from Northern blots as in Fig. 1 and normalized with PABP mRNA used as unvariant standard. CAT activities of the L4L3-119L-PK/CAT construct transfected in each cell line were determined by the percentage of chloramphenicol conversion to its acetylated forms and expressed after standardization by the luciferase activity to correct for variable transfectability. Fold increase represents percent of conversion under 17 mM glucose induction/percent conversion under lactate conditions. Results are the mean of at least two experiments run separately. B, representative chromatograms of CAT experiments performed on extracts of mhAT1G8 and mhAT3F cells transfected with 5 µg of L4L3-119L-PK/CAT and 2 µg of pRSV-luciferase in a glucose-free medium and then cultured for 30 h in 10 mM lactate, 2 mM fructose, or 17 mM glucose. Slots were loaded with extract dilutions representative of constant luciferase activity.
[View Larger Version of this Image (35K GIF file)]

Forced Expression of GLUT 2 but Not of GLUT 1 Glucose Transporter in Cells Lacking GLUT 2 Restores Some Glucose Responsiveness to the L-PK Promoter

To study the effect of GLUT2 (or GLUT1) on the glucose responsiveness of the L-PK promoter, two hepatoma cell lines lacking GLUT 2, i.e. mhPKTf3 previously established3 and HepG2, were transiently transfected with L-PK CAT constructs and CMV-expression vectors for GLUT 1 or GLUT 2.

Immunofluorescence studies were performed to provide evidence of the GLUT 1 and GLUT 2 expression induced by transient transfection of the relevant vectors (Fig. 3A).


Fig. 3. Effect of transient expression of GLUT 2 and GLUT 1 in cells lacking GLUT2 on glucose responsiveness of the L-PK promoter. A, immunofluorescence studies in mhPKTf3 cell line before and after transfection with GLUT expression vectors. mhPKTf3 cells expressed mainly GLUT 1 (top left) as shown by the immunofluorescence staining at the surface membrane of the cells and no detectable level of GLUT 2 (bottom left). When transfected with GLUT expression vector, 4-5% of cells exhibited a very high fluorescence located around the plasma membrane of the cells. The fluorescence intensity of these transfected cells was so high that the fluorescence of non-transfected cells could no longer be detected, not even the GLUT 1-specific fluorescence. B, 5 µg of either L4L3-119L-PK/CAT or -119L-PK/CAT constructs were co-transfected with 1 µg of CMV, CMV-GLUT 2, or CMV-GLUT 1 expression vectors in two cell lines lacking GLUT 2, mhPKTf3, and HepG2. Cells were maintained for 8 h in a glucose-free medium, transfected for 16 h in the same medium, and then cultured for another 24 h either in lactate (LO), 17 mM glucose (G17), or 17 mM fructose (F17). CAT activities were measured as described under "Materials and Methods." The glucose responsiveness of the L-PK promoter was expressed as the ratio of the L4L3-119L-PK/CAT activity to the -119-L-PK/CAT activity. Results are the mean + S.E. of four separate experiments. Statistical significance between LO and G17 culture conditions: *, p < 0.01; ***, p < 0.001. Statistical significance between CMV-vector versus GLUT 2-vector transfected cells in the same medium: open circle , p < 0.05; open circle open circle , p < 0.02.
[View Larger Version of this Image (43K GIF file)]

In the mhPKTf3 cell line, GLUT 1 immunofluorescence was easily detectable at the plasma membrane of the cells while no membrane-associated GLUT 2 immunofluorescence was observed. When mhPKTf3 cells were transfected with CMV-GLUT 1 or CMV-GLUT 2 expression vectors, 4-5% of the cells exhibited greatest immunofluorescence at the plasma membrane level, confirming the correct localization of the forced expressed transporters.

Response of the L4L3-L-PK promoter to glucose was calculated by dividing the CAT activities with the glucose-sensitive L4L3-119L-PK/CAT construct by those of with glucose insensitive -119L-PK/CAT construct (Fig. 3 B). Glucose responsiveness was nil in mhPKTf3 cells and very weak (× 1.58) in HepG2 cells. Co-transfection with the GLUT 2 expression vector resulted in a clear and significant L-PK glucose responsiveness in both cell lines (3.0- and 3.8-fold increase between lactate (Fig. 3B, LO) and glucose (Fig. 3B, G17) medium in mhPKTf3 and HepG2 cells, respectively). In HepG2 cells, 17 mM fructose stimulated the L-PK promoter almost as efficiently as glucose, which confirms that GLUT 2 synthesized by transfected cells was active on fructose entry into the cells (30). Interestingly, the response to glucose in HepG2 cells resulted in both decreased activity of the L-PK promoter under lactate conditions (× 0.70) and increased activity under glucose condition (× 1.70). In contrast, forced expression of GLUT 1 in these cells, which already synthesize GLUT 1 (Fig. 3A), did not significantly change glucose responsiveness of the L-PK promoter.

Induction of GLUT2 Expression by Selection of Clones in a Fructose Medium Parallels the Appearance of Glucose Responsiveness of the L-PK Gene

We observed that most of the clones isolated in our laboratory that exhibit a high GLUT 2 expression and, thus, a good glucose responsiveness had been selected for "liver-specific functions" by culture in a medium in which glucose was replaced by 2 mM fructose (2). Initially, in designing these conditions, we wanted to select cells able to use fructose efficiently through their endogenous fructokinase and aldolsase B, two enzymes specific to liver, kidney, and small intestine (31). In fact, we also selected for the expression of GLUT 2, a transporter permissive for fructose transport (30). Accordingly, we subjected mhPKTf3 cells, which had never been selected by culture with fructose before, to fructose selection.

Fig. 4, A and B, shows that the amount of endogenous L-PK mRNA in mhPKTf3 GLUT 2(-) cells was rather independent of glucose (× 1.8) before selection and became significantly glucose-responsive in fructose-selected mhPKTf3F1 (× 3, 7) and mhPKTf3F2 (× 11) clones, concomitantly with appearance of GLUT 2 expression. Fig. 4C confirms that the recovery of GLUT 2 expression in mhPKTf3F1 clone is parallel with restoration of the L-PK promoter activation by glucose (× 2.5) or by fructose (× 2.4).


Fig. 4. Effect of the cloning of GLUT 2(-) cells in glucose-free fructose medium on restoration of glucose responsiveness of the L-PK promoter. GLUT 2 endogenous expression and L-PK gene activation in fructose-selected mhPKTf3F1 and mhPKTf3F2 clones were compared with results in the parental mhPKTf3, GLUT 2(-) cell line. A, representative Northern blots. Analysis of GLUT 2 and L-PK endogenous gene expression by Northern blot in cells cultured in a glucose-free medium for 24 h and then in 5 mM or 17 mM glucose for another 24 h. The cDNA probe used to hybridize the mouse L-PK mRNA was of rat origin and allowed us to detect mRNA encoded by the M2-PK isoform gene. B, histograms quantitating the glucose responsiveness of the L-PK endogenous gene. Results are the mean + S.E. of three separate experiments. Statistical significance between results in mhPKTf3 and mhPKTf3F (either F1 or F2) at 17 mM glucose: *, p < 0.01; ***, p < 0.001. C, transcriptional response to hexoses of the L4L3-119-L-PK/CAT construct transiently transfected in the different cell lines. The L-PK/CAT activation mediated by the glucose response region, L4L3, was assessed as described in Fig. 3. Results are the mean + S.E. of three separate experiments. Statistical significance between results of mhPKTf3F1 under lactate (LO) and 17 mM glucose (G17) conditions: **, p < 0.01. Statistical significance between LO and 17 mM fructose (F17): *, p < 0.05.
[View Larger Version of this Image (27K GIF file)]

In GLUT 2(+) cells, L-PK and GLUT 2 Genes Are Similarly Regulated by Glucose

The GLUT 2 gene is known to be regulated by glucose (3, 28, 29). We raised the question of whether the kinetics of glucose responsiveness of the GLUT 2 and L-PK genes were similar or different in mhAT3F cells. Fig. 5 shows that time course (Fig. 5B) and concentration dependence of the response of the endogenous GLUT 2 and L-PK genes to glucose (Fig. 5C) were practically similar, both requiring active protein synthesis and, therefore, being blocked by translation inhibitors such as cycloheximide and anisomycin (Fig. 5A). However, these results did not preclude that a major cause of the delay of L-PK gene response to glucose (and perhaps of its dependence on active protein synthesis) could be the need for active GLUT 2 protein synthesis. In fact, the same requirement could exert itself on GLUT 2 mRNA accumulation, with GLUT 2 gene induction by glucose being subjected, in such a case, to a positive auto-regulatory loop. Fig. 5A also shows that mhAT3F cells expressed the GLUT 1 and HK 1 genes regardless of the presence of glucose in the medium and with a low sensitivity to translation inhibitors. In contrast, these cells, like all the lines used in this study or reported in the literature (2, 8, 9), were devoid of glucokinase gene expression (not shown).

GLUT 2 Production from an Expression Vector Neutralizes the Latency of L-PK Gene Transcription by Glucose in mhAT3F Cells

To further test the hypothesis that the need for previous GLUT 2 synthesis could be involved in the delayed response of the L-PK gene to glucose in cells deprived of glucose for more than 30 h before induction, we forced the expression of GLUT 2 in mhAT3F cells cultured in lactate for 64 h (endogenous GLUT 2 mRNA being absent) and then analyzed the time course of the L4L3-119L-PK/CAT construct activation by glucose (Fig. 6B). As recalled in Fig. 6A, when mhAT3F cells were deprived of glucose for more than 30 h, activation of the L-PK promoter was very low until the 14th h (2) while induction was more rapid after glucose deprivation of only 15 h. In cells that accumulated exogenous GLUT 2 for 24 h before glucose switch, the L-PK promoter was already activated 2.5- and 3.8-fold after 2 and 6 h of glucose refeeding, respectively. GLUT 2 overexpression resulted in both decreased activity under lactate conditions and increased activity under high glucose conditions (Fig. 6C). In contrast, overexpression of GLUT 1 tended rather to decrease the response to glucose (Fig. 6B), particularly by increasing activity of the L-PK promoter in cells cultured in the presence of lactate (Fig. 6C), as also observed in mhPKTf3 and HepG2 cells (Fig. 3).


Fig. 6. Effect of forced GLUT 2 expression in mhAT3F cells on induction of the L-PK gene by glucose. mhAT3F cells were co-transfected with 5 µg of L4L3-119L-PK/CAT and 1 µg of pCMV-, or pCMV-GLUT 2, or pCMV-GLUT 1 in glucose-free medium and then induced with 17 mM glucose according to different protocols. A, the glucose activation of L-PK gene expression is delayed in mAT3F cells when cells are deprived of glucose for >30 h before induction by glucose (black-square-black-square). (Results are drawn similar to those presented in Fig. 3 of Ref. 2.) However, activation was more rapid when glucose deprivation was short (15 h) (open circle -open circle ). B and C, effect of forced expression of GLUT 2 or GLUT 1 on the time-course of L-PK gene activation by glucose. Cells were cultured for 24 h before transfection in a lactate medium containing 4% (w/v) dialyzed fetal calf serum, transfected for 16 h in a serum-free lactate medium, and then kept for a further 24 h in 4% dialyzed fetal calf serum lactate medium before glucose induction for 2, 4, or 6 h. Cells were harvested 48 h after the beginning of the transfection. Results of panels B and C are given as mean + S.E. of the same four separate experiments except that, in panel B, results are expressed in -fold of glucose stimulation and, in panel C, in percent acetylation. Statistical significance compared with time 0 of the same experiment: *, p < 0.001; statistical significance compared with time 0 of the experiment using the void CMV expression vector: open circle , p < 0.001.
[View Larger Version of this Image (24K GIF file)]

GLUT 2 Expression Is Associated with Glu-6-P Depletion in GLUT 2(+) Hepatoma Cells When Cultured in Gluconeogenic Conditions

Activation of the L-PK promoter by glucose requires Glu-6-P accumulation (9). The permanent transcription of the L-PK gene in GLUT 2(-) cells cultured in lactate suggested that Glu-6-P produced by the gluconeogenic pathway might remain at a high concentration in these cells while it may be low in GLUT 2(+) cells. To test this hypothesis, GLUT 2(-) lines (mhPKTf3 and HepG2 cells) and GLUT 2(+) lines (mhPKTf3F1 and mhAT3F cells) were cultured for 30-40 h in a lactate-containing, glucose-free medium, and intracellular Glu-6-P was assayed. Its value was compared with that observed after 1 h of culture in the presence of 17 mM glucose. Table I shows that Glu-6-P was practically undetectable in mhAT3F and mhPKTf3F1 cells cultured for 30 h in lactate and slightly increased at the 40th h. In contrast, it was about 80% of the values obtained after 1 h of culture in a high glucose medium in mhPKTf3 and HepG2 cells. This high Glu-6-P concentration in GLUT 2(-) hepatoma cells cultured without glucose easily explains the glucose-independent activity of the L-PK promoter and gene in these cells.

Table I. Glucose 6-phosphate concentration in nmol per mg of protein


Glucose at 1 h Lactate at 30 h Lactate at 40 h

GLUT 2(+)
  mhAT3F 2.62  (2.51-2.85) 0 0.73  (0.57-0.85)
  mhPKTf3F1 2.22  (1.79-2.89) 0.15  (0-0.45) 0.39  (0-0.85)
GLUT 2(-)
  mhPKTf3 3.03  (2.44-3.48) 2.39  (1.79-2.91) 2.48  (1.88-2.86)
  HepG2 2.56  (2.36-2.79) NDa 2.14

a ND, not determined.


DISCUSSION

Hepatocytes and beta  cells were the only cells to express the couple "GLUT 2-glucokinase" for transport and phosphorylation of glucose from the blood. In the hepatoma cell lines described to date, neither GLUT 2 nor glucokinase were ever reported to be significantly expressed, being replaced by GLUT 1 and insulin-independent hexokinase isoforms, mainly HK 1 (8, 16). We have previously established and characterized various new hepatoma cell lines, some of which express GLUT 2 but not glucokinase and yet are responsive to glucose (2, 19, 20). Hepatoma cells that express mostly GLUT 1 exhibit a glucose-independent L-PK gene expression, whereas GLUT 2(+) cell lines express the L-PK gene poorly under glucose-free conditions and strongly under glucose conditions. Induction of GLUT 2 synthesis in GLUT 2(-) cells, either by selection for ability to grow in a fructose medium or by transient transfection of a GLUT 2 expression vector, allows for concomitant occurrence of glucose responsiveness of the L-PK promoter.

Thus, the main question is what is the mechanism of GLUT 2 action on the response of glucose-sensitive genes to glucose in liver cells? In other words, what does GLUT 2 do that GLUT 1 is unable to do ? GLUT 1 and GLUT 2 have similar Vmax, but affinity of GLUT 1 is 2-3-fold higher than that of GLUT 2. In addition, GLUT 1 is highly asymmetrical, much more efficient for glucose influx than efflux, wheras GLUT 2 is symmetrical, which explains its specific role in organs whose function is to secrete glucose (11). Finally, GLUT 2 but not GLUT 1 is capable to transport fructose (30).

In endocrine pancreas beta  cells, the predominant glucose-sensor has been definitively identified as glucokinase by knock out of the gene in mice (32, 33), and the significance of the specific GLUT 2 expression in rodent beta  cells is still disputed, especially as the amount of the GLUT 2 isoform seems to be very low in human beta  cells (34, 35). German (36) has shown that beta  cells overexpressing GLUT 1 do not lose their ability to sense changes in glucose concentration within the physiological range and to respond by an appropriate stimulation of the insulin gene promoter. In contrast, Newgard and co-workers (12, 26) hypothesized that GLUT 2, perhaps by specific interaction with glucokinase, could generate an intracellular signal needed for the response of insulin secretion to glucose. This view is consistent with the report by Valera et al. that, in mice, an antisense GLUT 2 mRNA impaired the normal activation of insulin secretion by glucose (37). Therefore, GLUT 2 could be needed to allow normal regulation for insulin secretion by glucose in beta  cells, at least in rodents, but be non-essential for glucose-dependent regulation of insulin gene transcription.

A glucose sensor system is also essential in the liver to provide a correct metabolic response to dietary modifications, either glucose utilization and glycogen storage or glucose production. This sensor seems to be composed, as in beta  cells, of GLUT 2 and glucokinase. However, glucokinase could be replaced by other insulin-independent hexokinases, in vivo and ex vivo. In vivo, knocked out mice specifically deficient in glucokinase in liver have an almost normal glucose regulation (32), whereas deficiency in pancreas glucokinase leads to neonatal death from severe insulin-dependent diabetes mellitus (33). Ex vivo, we have shown that hepatoma cells with hexokinase 1 (2, and this paper) respond to glucose in modulating transcription of glucose-responsive genes, e.g. the L-PK gene. Thus, in contrast to the essential role of glucokinase in glucose-dependent insulin secretion by beta  cells, glucokinase seems to be needed in the liver mainly for phosphorylating glucose to Glu-6-P, a role that can be performed by other hexokinase isoforms as well. However, GLUT 2 seems to be essential for the liver glucose sensor function, as suggested by its requirement for the normal response of the L-PK gene to glucose in liver-derived cells.

We have found that the main effect of GLUT 2 does not seem to be to generate a positive signal needed for glucose action, but rather to allow for L-PK gene extinction in cells cultured in the absence of glucose. All the hepatoma cells used in this work are more or less capable of gluconeogenesis and, accordingly, several of them have been selected for persistence of liver-specific functions by prolonged culture in glucose-free media (18, 19). Therefore, hepatoma cells cultured under glucose-free conditions are expected to synthesize Glu-6-P and glucose, and to secrete glucose provided that Glu-6-Pase and the transporter specialized in glucose export, i.e. GLUT 2, are present.

In the absence of GLUT 2, glucose efflux from the cells might be limited. As a consequence, the sequestered intracellular glucose could be phosphorylated back to Glu-6-P in a sort of futile cycle by the constitutive hexokinase isoforms replacing glucokinase, resulting in a high Glu-6-P concentration. This hypothesis is in complete agreement with our results that hepatoma cells cultured for 30 or 40 h in lactate medium had a high Glu-6-P concentration when they are GLUT 2(-) and an undectable or low Glu-6-P concentration when they are GLUT 2(+). Intracellular Glu-6-P concentration in GLUT 2(+) cells seems to increase between hour 30 and 40 of culture in glucose-free medium (Table I). In fact, this result was not surprising because expression of the GLUT 2 gene is itself glucose-dependent (3). Consequently, prolonged culture in lactate medium should result in the progressive disappearance of the GLUT 2 transporter. Glu-6-P is the first glucose metabolite needed for the transcriptional response of glucose-responsive genes to glucose (4-6). Accumulation of this compound (and derivated glycolytic intermediates) in GLUT 2(-) cells cultured without glucose could therefore activate L-PK gene transcription. In contrast, GLUT 1 expression could contribute to limited glucose export or promote rapid reentry of glucose secreted in the extracellular medium.

In conclusion, our results provide a new insight into the correlation between expression of the GLUT 2 transporter and the physiological response to glucose observed in gluconeogenic cells. In hepatoma cell lines, the usually expressed "couple" for transport and phosphorylation of glucose is GLUT 1-HK1, whereas it is GLUT 2-glucokinase in the liver. We show in this paper that hepatoma cell lines that express the couple GLUT 2-HK1 conserve the sensitivity of metabolic genes to glucose concentration and suggest that GLUT 2 acts in this process more as a component of the gluconeogenic pathway than as an essential element for glucose influx. In vivo, GLUT 2 is present in the liver under both gluconeogenic and glycolytic conditions. Under the former condition, GLUT 2 activity would be essential for both glucose secretion and keeping the intracellular Glu-6-P concentration low and thus avoid permanent activation of glycolytic and lipogenic genes, which otherwise would result in a futile metabolic cycle and inappropriate energy dissipation.


FOOTNOTES

*   This work was supported in part by grants from La Ligue Nationale contre le Cancer and l'Association de Recherche sur le Cancer.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Fellow of the CNRS (Centre National de la Recherche Scientifique).
   To whom correspondence should be addressed: Tel.: 33-1 44 41 24 24; Fax: 33-1 44 41 24 21.
1   The abbreviations used are: HK, hexokinase; Glu-6-P, glucose 6-phosphate; L-PK, L-type pyruvate kinase; PABP, poly(A)-binding protein; CAT, chloramphenicol acetyltransferase; RSV, Rous sarcoma virus; CMV, cytomegalovirus; GlRE, glucose response element.
2   F. Levrat, unpublished results.
3   A. Vandewalle, unpublished results.

ACKNOWLEDGEMENTS

We are very grateful to Dr. Bernard Thorens (Lausanne, Switzerland) for the kind gift of the CMV-GLUT 2 and -GLUT 1 expression vectors as well as corresponding antisera. We also thank Dr. S. W. Cushman (Bethesda, MD) and Dr.Luc Pénicaud (Toulouse, France) for the gift of other anti-GLUT2 antisera. We thank Bruno Doiron and Franck Rencurel for technical advice on Glu-6-P measurement and Michel Raymondjean and Jean A. Boutin for critically reading the manuscript.


REFERENCES

  1. Vaulont, S., and Kahn, A. (1993) FASEB J. 8, 28-35 [Abstract/Free Full Text]
  2. Lefrançois-Martinez, A. M., Diaz-Guerra, M. J. M., Vallet, V., Kahn, A., and Antoine, B. (1993) FASEB J. 8, 89-96 [Abstract/Free Full Text]
  3. Rencurel, F., Waeber, G., Antoine, B., Rocchiccioli, F., Maulard, P., Girard, J., and Leturque, A. (1996) Biochem. J. 314, 903-909 [Medline] [Order article via Infotrieve]
  4. Foufelle, F., Gouhot, B., Pégorier, J.-P., Perdereau, D., Girard, J., and Ferré, P. (1992) J. Biol. Chem. 267, 20543-20546 [Abstract/Free Full Text]
  5. Marie, S., Diaz-Guerra, M.-J., Miquerol, L., Kahn, A., and Iynedjian, P. B. (1993) J. Biol. Chem. 268, 23881-23890 [Abstract/Free Full Text]
  6. Doiron, B., Cuif, M.-H., Chen, R., and Kahn, A. (1996) J. Biol. Chem. 271, 5321-5324 [Abstract/Free Full Text]
  7. Iynedjian, P. B. (1993) Biochem. J. 293, 1-13 [Medline] [Order article via Infotrieve]
  8. Arora, K. K., and Pedersen, P. L. (1988) J. Biol. Chem. 263, 17422-17428 [Abstract/Free Full Text]
  9. Doiron, B., Cuif, M.-H., Kahn, A., and Diaz-Guerra, M.-J. M. (1994) J. Biol. Chem. 269, 10213-10216 [Abstract/Free Full Text]
  10. Thorens, B., Sarkar, H. K., Kaback, H. R., and Lodish, H. F. (1988) Cell 55, 281-290 [Medline] [Order article via Infotrieve]
  11. Gould, G. W., and Holman, G. D. (1993) Biochem. J. 295, 329-341 [Medline] [Order article via Infotrieve]
  12. Hughes, S. D., Quaade, C., Johnson, J. H., Ferber, S., and Newgard, C. B. (1993) J. Biol. Chem. 268, 15205-15212 [Abstract/Free Full Text]
  13. Newgard, C. B. (1994) Diabetes 46, 341-350
  14. Lachaal, M., Spangler, R. A., and Jung, C. Y. (1993) Am. J. Physiol. 28, E914-E919
  15. Meienhofer, M. C., De Medicis, E., Cognet, M., and Kahn, A. (1987) Eur. J. Biochem. 169, 237-243 [Abstract]
  16. Flier, J. S., Mueckler, M. M., Usher, P., and Lodish, H. F. (1987) Science 235, 1492-1497 [Medline] [Order article via Infotrieve]
  17. Dubois, N., Bennoun, M., Allemand, I., Molina, T., Grimber, G., Daudet-Monsac, M., Abelanet, R., and Briand, P. (1991) J. Hepatol. 13, 227-239 [Medline] [Order article via Infotrieve]
  18. Cartier, N., Miquerol, L., Tulliez, M., Lepetit, N., Levrat, F., Grimber, G., Briand, P., and Kahn, A. (1992) Oncogene 7, 1413-1422 [Medline] [Order article via Infotrieve]
  19. Antoine, B., Levrat, F., Vallet, V., Berbar, T., Cartier, N., Dubois, N., Briand, P., and Kahn, A. (1992) Exp. Cell Res. 200, 175-185 [Medline] [Order article via Infotrieve]
  20. Levrat, F., Vallet, V., Berbar, T., Miquerol, L., Kahn, A., and Antoine, B. (1993) Exp. Cell Res. 209, 307-316 [CrossRef][Medline] [Order article via Infotrieve]
  21. Antoine, B., Courjault-Gautier, F., Bens, M., Vallet, V., Cluzeaud, H., Toutain, H., Pringault, E., Kahn, A., and Vandewalle, A. (1997) Exp. Cell Res. in press
  22. Chomzynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [CrossRef][Medline] [Order article via Infotrieve]
  23. Mueckler, M., and Lodish, H. F. (1986) Cell 44, 629-637 [Medline] [Order article via Infotrieve]
  24. Printz, R. L., Koch, S., Potter, L. R., O'Doherty, R. M., Tiesinga, J. J., Moritz, S., and Granner, D. K. (1993) J. Biol. Chem. 268, 5209-5219 [Abstract/Free Full Text]
  25. Bergot, M. O., Diaz-Guerra, M. J. M., Puzenat, N., Raymondjean, M., and Kahn, A. (1992) Nucleic Acids Res. 20, 1871-1878 [Abstract]
  26. Hughes, S. D., Johnson, J. H., Quaade, C., and Newgard, C. B. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 688-692 [Abstract]
  27. Slein, M. W. (1963) in Methods of Enzymatic Analysis (Bergmeyer, H. U., ed), pp. 1238-1242, Academic Press, New York
  28. Asano, T., Katagiri, H., Tsukuda, K., Lin, J. J., Ishihara, H., Yasaki, Y., and Oka, Y. (1992) Diabetes 41, 22-25 [Abstract]
  29. Postic, C., Burcelin, R., Rencurel, F., Pegorier, J. P., Girard, J., and Leturque, A. (1993) Biochem. J. 293, 119-124 [Medline] [Order article via Infotrieve]
  30. Gould, G. W., Thomas, H. M., Jess, T. J., and Bell, G. I. (1991) Biochemistry 30, 5139-5145 [Medline] [Order article via Infotrieve]
  31. Shapira, F., Shapira, G., and Dreyfus, J. C. (1961) Enzymol. Biol. Clin. 7, 170-175
  32. Grupe, A., Hultgren, B., Ryann, A., Hui Ma, Y., Bauer, M., and Stewart, T. A. (1995) Cell 83, 69-78 [Medline] [Order article via Infotrieve]
  33. Terauchi, Y., Sakura, H., Yasuda, K., Iwamoto, K., Takahashi, N., Ito, K., Kasai, H., Suzuki, H., Ueda, O., Kamada, H., Jishage, K., Komeda, K., Noda, M., Kanazawa, Y., Taniguchi, S., Miwa, I., Akanuma, Y., Komada, T., Yazaki, Y., and Kadowaki, T. (1995) J. Biol. Chem. 270, 30253-30256 [Abstract/Free Full Text]
  34. De Vos, A., Heimberg, H., Quartier, E., Bouwens, L., Pipeleers, D., and Schuit, F. (1995) J. Clin. Invest. 96, 2489-2495 [Medline] [Order article via Infotrieve]
  35. Ferrer, J., Benito, C., and Gomis, R. (1995) Diabetes 44, 1369-1374 [Abstract]
  36. German, M. S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1781-1785 [Abstract]
  37. Valera, A., Solanes, G., Fernandez-Alvarez, J., Pujol, A., Ferrer, J., Asins, G., Gomis, R., and Bosch, F. (1994) J. Biol. Chem. 269, 28543-28546 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.